Review: Risk factor assessment of erectile dysfunction

Abstract

Erectile dysfunction is a distressing condition that may result from organic or psychological causes. Organic ED results from neurological, hormonal or vascular pathologies, and may also have drug-related causes. Cardiovascular disease and diabetes are the most common vascular risk factors. Due to a reluctance of patients to mention ED, healthcare professionals should discuss sexual dysfunction with patients who have increased risk of ED. This article considers underlying aetiologies and outlines treatment options.

Keywords

erectile dysfunction vascular disease diabetes.

Get full access to this article

View all access options for this article.

References

NIH Consensus Development Panel on Impotence. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993;270:83-90.

Burchardt M. , Burchard T. , Anastasiadis AG et al. Erectile dysfunction is a marker for cardiovascular complications and psychological functioning in men with hypertension . Int J Impot Res 2001;13:276-81.

Feldman HA , Goldstein I. , Hatzichristou DG , Krane RJ , McKinlay JB Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.

Aytac IA , McKinlay JB , Krane RJ The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999;84:50-6.

Impotence Association. Survey: attitudes towards erectile dysfunction. London ; 2002.

Eardley I. Pathophysiology of erectile dysfunction. Br J Diabetes Vasc Dis 2002;2:272-6.

Jackson G. , Betteridge J. , Dean J. et al. A systematic approach to erectile dysfunction in the cardiovascular patient: a consensus statement update - 2002. Int J Clin Pract 2002;56:663-71.

Fedele D. , Bortolotti A. , Coscelli C. et al. Erectile dysfunction in type 1 and type 2 diabetics in Italy. On behalf of Gruppo Italiano Studio Deficit Erettile nei Diabetici. Int J Epidemiol 2000;29:524-31.

Jones RWA , Gingell JC The vascular system and erectile dysfunction in diabetes - the role of penile doppler. Br J Diabetes Vasc Dis 2002;2:263-5.

10.

Ellenberg M. Impotence in diabetes: the neurologic factor . Ann Intern Med 1971;75:213-19.

11.

Saenz de Tejada I. , Goldstein I. , Azadzoi K. , Krane RJ , Cohen RA Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989;320:1025-30.

12.

Cartledge JJ , Eardley I. , Morrison JF Nitric oxide-mediated corpus cavernosal smooth muscle relaxation is impaired in ageing and diabetes . BJU Int 2001;87:394-401.

13.

Seftel AD , Vaziri ND , Ni Z. et al. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS . Urology 1997;50:1016-26.

14.

Mannino DM , Klevens RM , Flanders WD

Cigarette smoking: an independent risk factor for impotence?

Am J Epidemiol 1994;140:1003-08.

15.

Chung WS , Sohn JH , Park YY

Is obesity an underlying factor in erectile dysfunction?

Eur Urol 1999;36:68-70.

16.

Araujo AB , Durante R. , Feldman HA , Goldstein I. , McKinlay JB The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 1998;60:458-65.

17.

Pagani M. Hypertension, stress and erectile dysfunction: potential insights from the analysis of heart rate variability. Curr Med Res Opin 2000;16(suppl 1):S3-S8.

18.

Guay A. , Spark R. , Bansal S. et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: a couple's problem - 2003 update. Endocr Pract 2003;9:77-95.

19.

Barksdale JD , Gardner SF The impact of first-line antihypertensive drugs on erectile dysfunction. Pharmacotherapy 1999;19:573-81.

20.

Singer C. , Weiner WJ , Sanchez-Ramos J. , Ackerman M. Sexual function in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1991; 54:942.

21.

Ghezzi A. , Malvestiti GM , Baldini S. , Zaffaroni M. , Zibetti A. Erectile impotence in multiple sclerosis: a neurophysiological study . J Neurol 1995; 242:123-6.

22.

Mirone V. , Imbimbo C. , Palmieri A. , Longo N. , Fusco F. Erectile dysfunction after surgical treatment. Int J Androl 2003;26:137-40.

23.

Ricchiuti V. , Haas C. , Seftel A. , Chelimsky T. , Goldstein I. Pudendal nerve injury associated with avid bicycling. J Urol 1999;162:2099-100.

24.

Munarriz R. , Yan Q. , Nehra A. , Udelson D. , Goldstein I. Blunt trauma: the pathophysiology of hemodynamic injury leading to erectile dysfunction . J Urol 1995;153:1831-40.

25.

Lue TF Erectile dysfunction. N Engl J Med 2000;342:1802-13.

26.

Miller T. Diagnostic evaluation of erectile dysfunction. Am Fam Physician 2000;61:95-104.

27.

Fahmy A. , Mitra S. , Blacklock A. , Desai K.

Is the measurement of serum testosterone routinely indicated in men with erectile dysfunction?

BJU Int 1999;84:482-4.

28.

Rosner W. Errors in the measurement of plasma testosterone. J Clin Endocrinol Metab 1997;82:2014-15.

29.

Marwick C. Survey says patients expect little physician help on sex. JAMA 1999;281:2173-4.

30.

Ali W. , Besarini D. , Kirby R. Modern treatment of erectile dysfunction. Br J Diabetes Vasc Dis 2002;2:255-61.